| MeSH term | MeSH ID | Detail |
|---|---|---|
| Alveolar Bone Loss | D016301 | 10 associated lipids |
| Learning Disorders | D007859 | 11 associated lipids |
| Hyperkinesis | D006948 | 11 associated lipids |
| Hyperinsulinism | D006946 | 27 associated lipids |
| Muscle Spasticity | D009128 | 5 associated lipids |
| Hypothermia | D007035 | 19 associated lipids |
| Celiac Disease | D002446 | 16 associated lipids |
| Dyskinesia, Drug-Induced | D004409 | 15 associated lipids |
| Ventricular Dysfunction, Left | D018487 | 33 associated lipids |
| Hypertension, Portal | D006975 | 12 associated lipids |
Anandamide
Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.
Cross Reference
Introduction
To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Anandamide?
Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Anandamide
PubChem Associated disorders and diseases
What pathways are associated with Anandamide
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Anandamide?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Anandamide?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Anandamide?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Anandamide?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Anandamide?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Anandamide
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Naidu PS et al. | Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. | 2007 | Psychopharmacology (Berl.) | pmid:17279376 |
| Sun Y et al. | Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism. | 2007 | Br. J. Pharmacol. | pmid:17906680 |
| Rubio M et al. | Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. | 2007 | Neurosci. Lett. | pmid:17574742 |
| Ryberg E et al. | The orphan receptor GPR55 is a novel cannabinoid receptor. | 2007 | Br. J. Pharmacol. | pmid:17876302 |
| Mulè F et al. | Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon. | 2007 | Pharmacol. Res. | pmid:17574859 |
| Karsak M et al. | Attenuation of allergic contact dermatitis through the endocannabinoid system. | 2007 | Science | pmid:17556587 |
| Bátkai S et al. | Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats. | 2007 | Am. J. Physiol. Heart Circ. Physiol. | pmid:17557913 |
| Williams J et al. | Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS. | 2007 | Anal. Chem. | pmid:17600384 |
| Esposito G et al. | Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: in vitro and in vivo evidence. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17545311 |
| Karanian DA et al. | Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17545313 |
| Velenovská M and Fisar Z | Effect of cannabinoids on platelet serotonin uptake. | 2007 | Addict Biol | pmid:17508987 |
| Brizzi A et al. | Design, synthesis, binding, and molecular modeling studies of new potent ligands of cannabinoid receptors. | 2007 | Bioorg. Med. Chem. | pmid:17561406 |
| Hill MN et al. | Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity. | 2007 | J. Neurochem. | pmid:17561935 |
| Leweke FM et al. | Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use. | 2007 | Schizophr. Res. | pmid:17566707 |
| Ali AB | Presynaptic Inhibition of GABAA receptor-mediated unitary IPSPs by cannabinoid receptors at synapses between CCK-positive interneurons in rat hippocampus. | 2007 | J. Neurophysiol. | pmid:17567776 |
| Fischbach T et al. | Effects of anandamide and noxious heat on intracellular calcium concentration in nociceptive drg neurons of rats. | 2007 | J. Neurophysiol. | pmid:17581853 |
| Raduner S et al. | Self-assembling cannabinomimetics: supramolecular structures of N-alkyl amides. | 2007 | J. Nat. Prod. | pmid:17497806 |
| Wang Y and Wang DH | Neural control of blood pressure: focusing on capsaicin-sensitive sensory nerves. | 2007 | Cardiovasc Hematol Disord Drug Targets | pmid:17346127 |
| Basavarajappa BS | Critical enzymes involved in endocannabinoid metabolism. | 2007 | Protein Pept. Lett. | pmid:17346227 |
| Jia Y and Lee LY | Role of TRPV receptors in respiratory diseases. | 2007 | Biochim. Biophys. Acta | pmid:17346945 |
| Solinas M et al. | Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17351107 |
| Centonze D et al. | The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. | 2007 | Brain | pmid:17626034 |
| Spivak CE et al. | The endocannabinoid anandamide inhibits the function of alpha4beta2 nicotinic acetylcholine receptors. | 2007 | Mol. Pharmacol. | pmid:17628012 |
| Thors L et al. | Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake. | 2007 | Br. J. Pharmacol. | pmid:17676056 |
| Oz M et al. | The endogenous cannabinoid anandamide inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17682128 |
| Mulè F et al. | Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations. | 2007 | Pharmacol. Res. | pmid:17656103 |
| Iuvone T et al. | Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro. | 2007 | J. Mol. Med. | pmid:17639288 |
| Eisenstein TK et al. | Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors. | 2007 | J. Neuroimmunol. | pmid:17640739 |
| Akerman S et al. | Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17018694 |
| Shimozawa N et al. | Estrogen and isoflavone attenuate stress-induced gastric mucosal injury by inhibiting decreases in gastric tissue levels of CGRP in ovariectomized rats. | 2007 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:17023553 |
| Varvel SA et al. | Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task. | 2007 | Neuropsychopharmacology | pmid:17047668 |
| Yang YY et al. | Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis. | 2007 | Liver Int. | pmid:17845532 |
| Ghasemi M et al. | Anandamide improves the impaired nitric oxide-mediated neurogenic relaxation of the corpus cavernosum in diabetic rats: involvement of cannabinoid CB1 and vanilloid VR1 receptors. | 2007 | BJU Int. | pmid:17850365 |
| Cisneros JA et al. | Structure-activity relationship of a series of inhibitors of monoacylglycerol hydrolysis--comparison with effects upon fatty acid amide hydrolase. | 2007 | J. Med. Chem. | pmid:17764163 |
| Evans RM et al. | Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk. | 2007 | Br. J. Pharmacol. | pmid:17700720 |
| Wheal AJ et al. | Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats. | 2007 | Br. J. Pharmacol. | pmid:17700721 |
| Ho WS and Randall MD | Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. | 2007 | Br. J. Pharmacol. | pmid:17245358 |
| Hiley CR and Hoi PM | Oleamide: a fatty acid amide signaling molecule in the cardiovascular system? | 2007 | Cardiovasc Drug Rev | pmid:17445087 |
| Nucci C et al. | Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats. | 2007 | Invest. Ophthalmol. Vis. Sci. | pmid:17591864 |
| Matta JA et al. | TRPV1 is a novel target for omega-3 polyunsaturated fatty acids. | 2007 | J. Physiol. (Lond.) | pmid:17038422 |
| Ortar G et al. | New N-arachidonoylserotonin analogues with potential "dual" mechanism of action against pain. | 2007 | J. Med. Chem. | pmid:18027904 |
| Degenhardt BF et al. | Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study. | 2007 | J Am Osteopath Assoc | pmid:17908831 |
| Xu H et al. | Functional effects of nonsynonymous polymorphisms in the human TRPV1 gene. | 2007 | Am. J. Physiol. Renal Physiol. | pmid:17913835 |
| Athanasiou A et al. | Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. | 2007 | Biochem. Biophys. Res. Commun. | pmid:17931597 |
| Morgese MG et al. | Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. | 2007 | Exp. Neurol. | pmid:17900568 |
| Hillard CJ et al. | Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase. | 2007 | J. Mol. Neurosci. | pmid:17901541 |
| Opitz CA et al. | Production of the endocannabinoids anandamide and 2-arachidonoylglycerol by endothelial progenitor cells. | 2007 | FEBS Lett. | pmid:17904123 |
| Romano MR and Lograno MD | Evidence for the involvement of cannabinoid CB1 receptors in the bimatoprost-induced contractions on the human isolated ciliary muscle. | 2007 | Invest. Ophthalmol. Vis. Sci. | pmid:17652738 |
| Bentzen PJ and Lang F | Effect of anandamide on erythrocyte survival. | 2007 | Cell. Physiol. Biochem. | pmid:17975305 |
| Mukhopadhyay S and Tulis DA | Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke. | 2007 | Cardiovasc Hematol Agents Med Chem | pmid:17979695 |